Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Treasury Shares (2021 - 2025)

Rani Therapeutics Holdings (RANI) has 5 years of Treasury Shares data on record, last reported at $416305.0 in Q3 2025.

  • For Q3 2025, Treasury Shares fell 53.4% year-over-year to $416305.0; the TTM value through Sep 2025 reached $416305.0, down 53.4%, while the annual FY2024 figure was $811893.0, 36.38% down from the prior year.
  • Treasury Shares reached $416305.0 in Q3 2025 per RANI's latest filing, down from $485083.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.3 million in Q4 2023 and bottomed at $96363.0 in Q1 2022.
  • Average Treasury Shares over 5 years is $638653.4, with a median of $659184.5 recorded in 2022.
  • Peak YoY movement for Treasury Shares: skyrocketed 488.04% in 2022, then crashed 53.4% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $113173.0 in 2021, then surged by 488.04% to $665500.0 in 2022, then soared by 91.75% to $1.3 million in 2023, then tumbled by 36.38% to $811893.0 in 2024, then crashed by 48.72% to $416305.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $416305.0 in Q3 2025, $485083.0 in Q2 2025, and $652869.0 in Q1 2025.